Dr. Kimberly S. Strickland
Claim this profileNovant Health Presbyterian Medical Center
Area of expertise
Breast Cancer
Kimberly S. Strickland has run 4 trials for Breast Cancer. Some of their research focus areas include:
Breast Cancer
Kimberly S. Strickland has run 3 trials for Breast cancer. Some of their research focus areas include:
Affiliated Hospitals
Novant Health Presbyterian Medical Center
Novant Health Cancer Institute - Huntersville
Clinical Trials Kimberly S. Strickland is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting
2 awards
Phase 3
19 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting
2 awards
Phase 3
19 criteria
More about Kimberly S. Strickland
Clinical Trial Related
2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Kimberly S. Strickland has experience with
- Paclitaxel
- Pertuzumab
- Trastuzumab
- Trastuzumab Emtansine
- Tucatinib
- Carboplatin
Breakdown of trials Kimberly S. Strickland has run
Breast Cancer
Breast cancer
Esophageal cancer
Esophageal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kimberly S. Strickland specialize in?
Kimberly S. Strickland focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Kimberly S. Strickland currently recruiting for clinical trials?
Yes, Kimberly S. Strickland is currently recruiting for 2 clinical trials in Charlotte North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Kimberly S. Strickland has studied deeply?
Yes, Kimberly S. Strickland has studied treatments such as Paclitaxel, Pertuzumab, Trastuzumab.
What is the best way to schedule an appointment with Kimberly S. Strickland?
Apply for one of the trials that Kimberly S. Strickland is conducting.
What is the office address of Kimberly S. Strickland?
The office of Kimberly S. Strickland is located at: Novant Health Presbyterian Medical Center, Charlotte, North Carolina 28204 United States. This is the address for their practice at the Novant Health Presbyterian Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.